AF
AFGVF.US Agfa-Gevaert NV
- Market cap
- USD 88.4M
- P/E
- -
- P/B
- 0.49x
- ROE
- -31.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AFGVF.US undervalued?
Graham numberThe Graham number of Agfa-Gevaert NV cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Agfa-Gevaert NV fundamental analysis
No fundamental analysis for Agfa-Gevaert NV yet.
Agfa-Gevaert NV stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Agfa-Gevaert NV
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems in Belgium and internationally. The company provides healthcare's enterprise imaging platform. It also offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials,…
Full company profileAgfa-Gevaert NV financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Agfa-Gevaert NV annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.54B | 2.44B | 2.19B | 2.24B | 1.71B | 1.76B | 1.86B | 1.15B | 1.14B | 1.09B | 956M |
| Gross Profit | 857M | 814M | 702M | 729M | 494M | 497M | 528M | 358M | 354M | 328M | 270M |
| Operating Income | 211M | 160M | 75.0M | 40.0M | 23.0M | 29.0M | -10.0M | -8.00M | -48.0M | -11.0M | 4.20M |
| EBITDA | 228M | 193M | 117M | 64.0M | 14.0M | 77.0M | -75.0M | 48.0M | -18.0M | 25.0M | 28.2M |
| Net Income | 70.0M | 37.0M | -24.0M | -53.0M | -98.0M | -14.0M | -223M | -102M | -92.0M | -71.0M | -67.4M |
| EPS | 0.42 | 0.22 | -0.14 | -0.32 | -0.58 | -0.08 | -1.43 | -0.66 | -0.60 | -0.46 | -0.44 |
| Balance Sheet | |||||||||||
| Total Assets | 2.39B | 2.26B | 2.39B | 2.29B | 2.20B | 2.10B | 1.76B | 1.37B | 1.38B | 1.28B | 1.17B |
| Total Liabilities | 2.14B | 1.95B | 2.10B | 2.16B | 1.58B | 1.41B | 1.20B | 972M | 1.05B | 1.02B | 960M |
| Shareholders' Equity | 215M | 275M | 252M | 83.0M | 570M | 686M | 561M | 395M | 323M | 254M | 212M |
| Cash & Short-term Investments | 133M | 84.0M | 141M | 107M | 594M | 400M | 139M | 77.0M | 68.0M | 91.0M | 77.1M |
| Total Debt | 111M | 86.0M | 285M | 326M | 82.0M | 73.0M | 65.0M | 82.0M | 156M | 169M | 14.2M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 134M | 31.0M | -56.0M | 123M | -153M | -116M | -100M | -30.0M | -4.00M | 66.0M | -66.7M |
| Capital Expenditure | 44.0M | 46.0M | 40.0M | 38.0M | 33.0M | 26.0M | 33.0M | 34.0M | 45.0M | 34.0M | 29.1M |
| Free Cash Flow | 90.0M | -15.0M | -96.0M | 85.0M | -186M | -142M | -133M | -64.0M | -49.0M | 32.0M | -95.8M |
| Ratios | |||||||||||
| ROE | 32.6% | 13.5% | -9.5% | -63.9% | -17.2% | -2.0% | -39.8% | -25.8% | -28.5% | -28.0% | -31.8% |
| ROA | 2.9% | 1.6% | -1.0% | -2.3% | -4.4% | -0.7% | -12.7% | -7.5% | -6.7% | -5.6% | -5.7% |
| Net Profit Margin | 2.8% | 1.5% | -1.1% | -2.4% | -5.7% | -0.8% | -12.0% | -8.9% | -8.1% | -6.5% | -7.0% |
| Debt to Equity | 0.52x | 0.31x | 1.13x | 3.93x | 0.14x | 0.11x | 0.12x | 0.21x | 0.48x | 0.67x | 0.07x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Agfa-Gevaert NV dividends
Agfa-Gevaert NV has not paid dividends in the last 9 fiscal years.
Last stock split: 1093:1000 on Nov 24, 2010.
Who owns Agfa-Gevaert NV
- Insiders 0.00%
- Institutions 45.96%
- Public & others 54.04%
- Shares outstanding 155M
- Free float 160M
Agfa-Gevaert NV company profile
- Company name
- Agfa-Gevaert NV
- Ticker
- AFGVF.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 4,211
- Fiscal year end
- December
- Address
- Septestraat 27, Mortsel, Belgium, 2640
- Phone
- 32 3 444 71 24
- Website
- agfa.com
About Agfa-Gevaert NV
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems in Belgium and internationally. The company provides healthcare's enterprise imaging platform. It also offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry; and printable synthetic papers and films for graphics, non-destructive testing, aerial photography, and printed circuit board production. In addition, it provides analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. Further, it offers SmartXR that provides radiographers with predictive workflow assistance which includes digital radiography tools for dose, alignment, patient positioning, image rotation, and others. Additionally, the company engages in supply of film and chemicals, as well support services. It sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
Agfa-Gevaert NV management
10- Mr. Pascal JueryPresident, CEO, President of Radiology Solutions & Director · born 1965
- Mr. Michael Declan GuerinChief Financial Officer · born 1970
- Mr. Wilfried Van LishoutCompliance Officer & Company Secretary · born 1964
- Ms. Viviane DictusDirector of Corporate Communications
- Mr. Gunther KochChief Human Resources Officer & Head of Sustainability · born 1971
- Mr. Vincent WillePresident Digital Printing Solutions · born 1976
- Ms. Nathalie McCaughleyPresident of HealthCare IT · born 1973
- Ms. Gwendolien FonckPresident of Film & Chemicals
- Mr. Francois VerdeauxPresident of Digital Radiology Solutions
- Mr. Jorge TomásPresident of Green Hydrogen Solutions